downward-trend of SF(serum ferritin) over previous 6 months after reduction of chelation dose with continuation of regular transfusion regimen. 6 month [clinicaltrials_resource:eb83b7831ecf156c30b701c1e77161d6]
non inferiority of discounting chelation compared with continuing chelation in thalassemia patients with low serum ferritin and/or showing a downward-trend of SF(serum ferritin) over previous 6 months after reduction of chelation dose with continuation of regular transfusion regimen.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
downward-trend of SF(serum ferritin) over previous 6 months after reduction of chelation dose with continuation of regular transfusion regimen. 6 month [clinicaltrials_resource:eb83b7831ecf156c30b701c1e77161d6]
non inferiority of discounting chelation compared with continuing chelation in thalassemia patients with low serum ferritin and/or showing a downward-trend of SF(serum ferritin) over previous 6 months after reduction of chelation dose with continuation of regular transfusion regimen.
Bio2RDF identifier
eb83b7831ecf156c30b701c1e77161d6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:eb83b7831ecf156c30b701c1e77161d6
measure [clinicaltrials_vocabulary:measure]
downward-trend of SF(serum fer ...... f regular transfusion regimen.
time frame [clinicaltrials_vocabulary:time-frame]
description
non inferiority of discounting ...... f regular transfusion regimen.
identifier
clinicaltrials_resource:eb83b7831ecf156c30b701c1e77161d6
title
downward-trend of SF(serum fer ...... r transfusion regimen. 6 month
@en
type
label
downward-trend of SF(serum fer ...... 3b7831ecf156c30b701c1e77161d6]
@en